Plasma levels of apolipoprotein e and risk of intracranial artery stenosis in acute ischemic stroke patients

Annals of Nutrition and Metabolism

Volumn 62, Issue 1, 2013, Pages 26-31

  Kim, Yong Jae ^a   Lee, Seung Min ^b   Cho, Hyun Ji ^c   Do, Hyun Ju ^b   Hong, Chang Hyung ^d   Shin, Min Jeong ^b   Kim, Young Soon ^b  

^a Ewha Womans University   (South Korea)

^b Korea University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Ajou University School of Medicine   (South Korea)

Author keywords

Apolipoprotein E; Intracranial artery stenosis; Ischemic stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPOPROTEIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH KOREA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; CONTROLLED STUDY; INTRACRANIAL ARTERY STENOSIS; LIPID BLOOD LEVEL;

AGED; APOLIPOPROTEIN C-III; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHOLESTEROL, LDL; CONSTRICTION, PATHOLOGIC; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; INTRACRANIAL ARTERIOSCLEROSIS; LINEAR MODELS; LIPIDS; LIPOPROTEIN(A); LIPOPROTEINS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; STROKE; TRIGLYCERIDES;

EID: 84870291713     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000343789     Document Type: Article

References (32)

1. Gorelick PB, Wong KS, Bae HJ, Pandey DK: Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected front ier. Stroke 2008; 39: 2396-2399.
2. Bae HJ, Yoon BW, Kang DW, Koo JS, Lee SH, Kim KB, et al: Correlation of coronary and cerebral atherosclerosis: difference between extracranial and intracranial arteries. Cere-brovasc Dis 2006; 21:112-119.
3. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, et al: Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555-563.
4. Sacco RL, Kargman DE, Gu Q, Zamanillo MC: Race-ethnicity and determinants of in-tracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26: 14-20.
5. Fu JH, Chen YK, Chen XY, Mok V, Wong KS: Coexisting small vessel disease predicts poor long-term outcome in stroke patients with intracranial large artery atherosclerosis. Cerebrovasc Dis 2010; 30:433-439.
6. Liu LH, Caplan LR, Kwan E, Beldon JR, Ke DS, Nien CK: Racial differences in ischemic cerebrovascular disease: clinical and magnetic resonance angiographic correlations of white and Asian patients. J Stroke Cerebro-vasc Dis 1996; 6: 79-84.
7. Park KY, Chung CS, Lee KH, Kim GM, Kim YB, Oh K: Prevalence and risk factors of in-tracranial atherosclerosis in an asymptomatic Korean population. J Clin Neurol 2006; 2:29-33.
8. De Silva DA, Woon FP, Lee MP, Chen CP, Chang HM, Wong MC: South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke 2007; 38:2592-2594.
9. Lee SJ, Cho SJ, Moon HS, Shon YM, Lee KH, Kim DI, et al: Combined extracranial and in-tracranial atherosclerosis in Korean patients. Arch Neurol 2003; 60:1561-1564.
10. Arenillas JF, Molina CA, Chacon P, Rovira A, Montaner J, Coscojuela P, et al: High lipoprotein(a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004; 63:27-32.
11. Bae HJ, Lee J, Park JM, Kwon O, Koo JS, Kim BK, et al: Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cere-brovasc Dis 2007; 24: 355-360.
12. Turan TN, Makki AA, Tsappidi S, Cotsonis G, Lynn MJ, Cloft HJ, et al: Risk factors associated with severity and location of intra-cranial arterial stenosis. Stroke 2010; 41: 1636-1640.
13. Park JH, Kwon HM, Roh JK: Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol 2007; 14: 379-386.
14. Kim YJ, Kim OY, Cho Y, Chung JH, Jung YS, Hwang GS, Shin MJ: Plasma phospholipid fatty acid composition in ischemic stroke: importance of docosahexaenoic acid in the risk for intracranial artery stenosis. Atherosclerosis 2012, E-pub ahead of print.
15. Qureshi AI, Feldmann E, Gomez CR, Johnston SC, Kasner SE, Quick DC, et al: Intra-cranial atherosclerotic disease: an update. Ann Neurol 2009; 66:730-738.
16. Napoli C, Witztum JL, de Nigris F, Palumbo G, D'Armiento FP, Palinski W: Intracrani-al arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 1999; 99: 2003-2010.
17. Armstrong VW, Walli AK, Seidel D: Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res 1985; 26: 1314-1323.
18. Berg K: A new serum type system in man-the Lp system. Acta Pathol Microbiol Scand 1963; 59: 369-382.
19. Kim BS, Jung HS, Bang OY, Chung CS, Lee KH, Kim GM: Elevated serum lipoprotein(a) as a potential predictor for combined intra-cranial and extracranial artery stenosis in patients with ischemic stroke. Atherosclerosis 2010; 212:682-688.
20. D'Armiento FP, Bianchi A, de Nigris F, Capuzzi DM, D'Armiento MR, Crimi G, et al: Age-related effects on atherogenesis and scavenger enzymes of intracranial and extra-cranial arteries in men without classic risk factors for atherosclerosis. Stroke 2001; 32: 2472-2479.
21. Davignon J, Gregg RE, Sing CF: Apolipopro-tein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
22. Utermann G: Alzheimer's disease. The apo-lipoprotein E connection. Curr Biol 1994; 4: 362-365.
23. MO MC, Muir KW, Weir CJ, Dyker AG, Bone I, Nicoll JA, et al: The apolipoprotein E epsilon4 allele and outcome in cerebrovascu-lar disease. Stroke 1998; 29:1882-1887.
24. Horsburgh K, Fitzpatrick M, Nilsen M, Nicoll JA: Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat. Brain Res 1997; 763:103-110.
25. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset fa milies. Science 1993; 261: 921-923.
26. McCarron MO, DeLong D, Alberts MJ: APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999; 53: 1308-1311.
27. Kim KW, Youn JC, Han MK, Paik NJ, Lee TJ, Park JH, et al: Lack of association between apolipoprotein E polymorphism and vascular dementia in Koreans. J Geriatr Psychiatry Neurol 2008; 21:12-17.
28. Abboud S, Viiri LE, Lutjohann D, Goebeler S, Luoto T, Friedrichs S, et al: Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis. Eur J Hum Genet 2008; 16: 955-960.
29. Chutinet A, Suwanwela NC, Snabboon T, Chaisinanunkul N, Furie KL, Phanthum-chinda K: Association between genetic polymorphisms and sites of cervicocerebral artery atherosclerosis. J Stroke Cerebrovasc Dis 2012; 21: 379-385.
30. Beekman M, Heijmans BT, Martin NG, Pe-dersen NL, Whitfield JB, DeFaire U, et al: Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res 2002; 5:87-97.
31. van Vliet P, Westendorp RG, Eikelenboom P, Comijs HC, Frölich M, Bakker E, et al: Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels. Neurology 2009; 73: 681-687.
32. Park JH, Hong KS, Lee EJ, Lee J, Kim DE: High levels of apolipoprotein B/AI ratio are associated with intracranial atherosclerotic stenosis. Stroke 2011; 42:3040-3046.